Ascendis Pharma A/S

SecurityASND / Ascendis Pharma A/S
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Citadel Advisors Llc ownership in ASND / Ascendis Pharma A/S

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 0 shares of Ascendis Pharma A/S (US:ASND) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 519,516 shares of Ascendis Pharma A/S. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (ASND) in the form of stock options. The firm currently holds call options representing 57,600 of underlying shares valued at $13,174,848 USD and put options representing 10,000 of underlying shares valued at $2,287,300 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ASND / Ascendis Pharma A/S Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -519,516 -100.00 0 -100.00
2026-02-17 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 519,516 491,876 1,779.58 110,782 1,916.03 0.0166
2025-11-14 2025-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 27,640 -559,702 -95.29 5,495 -94.58 0.0008
2025-08-14 2025-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 587,342 -537,841 -47.80 101,375 -42.19 0.0176
2025-05-15 2025-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,125,183 229,199 25.58 175,371 42.17 0.0333
2025-02-14 2024-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 895,984 232,060 34.95 123,350 24.43 0.0213
2024-11-14 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 663,924 126,162 23.46 99,130 35.17 0.0191
2024-08-14 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 537,762 80,258 17.54 73,340 6.04 0.0148
2024-05-15 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 457,504 285,933 166.66 69,161 220.05 0.0133
2024-02-14 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 171,571 171,323 69,081.85 21,609 93,852.17 0.0043
2023-11-14 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 248 -13,724 -98.23 23 -98.16 0.0000
2023-08-14 2023-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 13,972 -107,030 -88.45 1,247 -90.39 0.0003
2023-05-15 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 121,002 -135,284 -52.79 12,974 -58.55 0.0029
2023-02-14 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 256,286 202,346 375.13 31,300 461.94 0.0073
2022-11-14 2022-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 53,940 -3,248 -5.68 5,570 4.78 0.0013
2022-08-15 2022-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 57,188 57,188 5,316 0.0014
2022-05-16 2022-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 0 -52,026 -100.00 0 -100.00
2022-02-14 2021-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 52,026 42,848 466.86 6,999 378.40 0.0014
2021-11-15 2021-09-30 13F ASCENDIS PHARMA A Depository Receipt 04351P101 9,178 -280,497 -96.83 1,463 -96.16 0.0003
2021-08-16 2021-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 289,675 174,760 152.08 38,107 157.31 0.0085
2021-05-21 2021-03-31 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 114,915 -205,099 -64.09 14,810 -72.25 0.0036
2021-05-17 2021-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 114,915 -205,099 14,810 0.0036
2021-02-16 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 320,014 -178,373 -35.79 53,372 -30.61 0.0139
2020-11-16 2020-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 498,387 24,144 5.09 76,911 9.65 0.0218
2020-08-14 2020-06-30 13F ASCENDIS PHARMA A S Depository Receipt 04351P101 474,243 227,543 92.23 70,141 152.48 0.0250
2020-05-15 2020-03-31 13F ASCENDIS PHARMA A S Depository Receipt 04351P101 246,700 -82,982 -25.17 27,781 -39.43 0.0125
2020-02-14 2019-12-31 13F ASCENDIS PHARMA A S Depository Receipt 04351P101 329,682 320,970 3,684.23 45,866 5,366.75 0.0199
2019-11-14 2019-09-30 13F ASCENDIS PHARMA A S Depository Receipt 04351P101 8,712 -63,356 -87.91 839 -89.89 0.0004
2019-08-14 2019-06-30 13F ASCENDIS PHARMA A S Depository Receipt 04351P101 72,068 -233,808 -76.44 8,299 -76.95 0.0038
2019-05-15 2019-03-31 13F ASCENDIS PHARMA A S Depository Receipt 04351P101 305,876 209,267 216.61 36,002 494.78 0.0179
2019-02-14 2018-12-31 13F ASCENDIS PHARMA A S Depository Receipt 04351P101 96,609 86,760 880.90 6,053 767.19 0.0033
2018-11-13 2018-09-30 13F ASCENDIS PHARMA A S Depository Receipt 04351P101 9,849 -16,829 -63.08 698 -60.68 0.0003
2018-08-14 2018-06-30 13F/A-1 ASCENDIS PHARMA A S Depository Receipt 04351P101 26,678 26,678 1,775 0.0009
2018-08-10 2018-06-30 13F ASCENDIS PHARMA A S Depository Receipt 04351P101 26,678 26,678 1,775
2018-02-09 2017-12-31 13F ASCENDIS PHARMA A S Depository Receipt 04351P101 0 -10,273 -100.00 0 -100.00
2017-11-09 2017-09-30 13F ASCENDIS PHARMA A S Depository Receipt 04351P101 10,273 10,273 372 0.0003
2017-01-31 2016-03-31 13F/A-1 ASCENDIS PHARMA A Depository Receipt 04351P101 0 -1,156 -100.00 0 -100.00
2017-01-31 2015-12-31 13F/A-1 ASCENDIS PHARMA A S Depository Receipt 04351P101 1,156 -2,531 -68.65 21 -67.69 0.0000
2016-02-12 2015-12-31 13F ASCENDIS PHARMA A Depository Receipt 04351P101 1,156 21
2015-11-16 2015-09-30 13F ASCENDIS PHARMA A Depository Receipt 04351P101 3,687 3,687 0.00 65 0.0001
2015-08-14 2015-06-30 13F ASCENDIS PHARMA A Depository Receipt 04351P101 0 -60,316 -100.00 0 -100.00
2015-05-15 2015-03-31 13F ASCENDIS PHARMA A Depository Receipt 04351P101 60,316 60,316 1,046 0.0012
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 57,600 -5.11 13,175 1.78 n/a n/a n/a
2026-02-17 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 60,700 -35.29 12,944 -30.59 n/a n/a n/a
2025-11-14 2025-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 93,800 376.14 18,648 448.47 n/a n/a n/a
2025-08-14 2025-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 19,700 -32.30 3,400 -25.03 n/a n/a n/a
2025-05-15 2025-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 29,100 140.50 4,536 172.37 n/a n/a n/a
2025-02-14 2024-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 12,100 -38.89 1,666 -43.67 n/a n/a n/a
2024-11-14 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 19,800 -39.26 2,956 -33.50 n/a n/a n/a
2024-08-14 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 32,600 111.69 4,446 90.94 n/a n/a n/a
2024-05-15 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 15,400 -34.19 2,328 -21.00 n/a n/a n/a
2024-02-14 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 23,400 25.13 2,947 68.30 n/a n/a n/a
2023-11-14 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 18,700 -70.83 1,751 -69.39 n/a n/a n/a
2023-08-14 2023-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 64,100 21.40 5,721 1.04 n/a n/a n/a
2023-05-15 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 52,800 -40.41 5,661 -47.68 n/a n/a n/a
2023-02-14 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 88,600 -46.07 10,821 -36.23 n/a n/a n/a
2022-11-14 2022-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 164,300 114.49 16,966 138.25 n/a n/a n/a
2022-08-15 2022-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 76,600 -42.10 7,121 -54.14 n/a n/a n/a
2022-05-16 2022-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 132,300 902.27 15,527 774.27 n/a n/a n/a
2022-02-14 2021-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 13,200 -69.86 1,776 -74.56 n/a n/a n/a
2021-11-15 2021-09-30 13F ASCENDIS PHARMA A Depository Receipt Call 43,800 250.40 6,981 324.64 n/a n/a n/a
2021-08-16 2021-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 12,500 7.76 1,644 9.97 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ASCENDIS PHARMA A SPONSORED ADR Call 11,600 48.72 1,495 14.91 n/a n/a n/a
2021-05-17 2021-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 11,600 1,495 n/a n/a n/a
2021-02-16 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 7,800 -36.07 1,301 -30.91 n/a n/a n/a
2020-11-16 2020-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 12,200 -42.99 1,883 -40.51 n/a n/a n/a
2020-08-14 2020-06-30 13F ASCENDIS PHARMA A S Depository Receipt Call 21,400 28.14 3,165 68.26 n/a n/a n/a
2020-05-15 2020-03-31 13F ASCENDIS PHARMA A S Depository Receipt Call 16,700 -83.99 1,881 -87.04 n/a n/a n/a
2020-02-14 2019-12-31 13F ASCENDIS PHARMA A S Depository Receipt Call 104,300 96.05 14,510 183.18 n/a n/a n/a
2019-11-14 2019-09-30 13F ASCENDIS PHARMA A S Depository Receipt Call 53,200 -71.58 5,124 -76.23 n/a n/a n/a
2019-08-14 2019-06-30 13F ASCENDIS PHARMA A S Depository Receipt Call 187,200 -44.27 21,556 -45.48 n/a n/a n/a
2019-05-15 2019-03-31 13F ASCENDIS PHARMA A S Depository Receipt Call 335,900 1,530.58 39,535 2,962.35 n/a n/a n/a
2019-02-14 2018-12-31 13F ASCENDIS PHARMA A S Depository Receipt Call 20,600 48.20 1,291 31.07 n/a n/a n/a
2018-11-13 2018-09-30 13F ASCENDIS PHARMA A S Depository Receipt Call 13,900 28.70 985 37.19 n/a n/a n/a
2018-08-14 2018-06-30 13F/A ASCENDIS PHARMA A S Cmn Call 10,800 718 n/a n/a n/a
2018-08-10 2018-06-30 13F ASCENDIS PHARMA A S Cmn Call 10,800 718 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 10,000 -46.52 2,287 -42.64 n/a n/a n/a
2026-02-17 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 18,700 122.62 3,988 138.74 n/a n/a n/a
2025-11-14 2025-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 8,400 110.00 1,670 142.03 n/a n/a n/a
2025-08-14 2025-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 4,000 -41.18 690 -34.84 n/a n/a n/a
2025-05-15 2025-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 6,800 -46.46 1,060 -39.42 n/a n/a n/a
2025-02-14 2024-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 12,700 -52.43 1,748 -56.15 n/a n/a n/a
2024-11-14 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 26,700 246.75 3,987 279.62 n/a n/a n/a
2024-08-14 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 7,700 -2.53 1,050 -12.06 n/a n/a n/a
2024-05-15 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 7,900 54.90 1,194 85.98 n/a n/a n/a
2024-02-14 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 5,100 -64.34 642 -52.05 n/a n/a n/a
2023-11-14 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 14,300 -22.28 1,339 -18.45 n/a n/a n/a
2023-08-14 2023-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 18,400 82.18 1,642 51.76 n/a n/a n/a
2023-05-15 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 10,100 -68.34 1,083 -72.22 n/a n/a n/a
2023-02-14 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 31,900 325.33 3,896 403.23 n/a n/a n/a
2022-11-14 2022-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 7,500 -43.18 774 -36.92 n/a n/a n/a
2022-08-15 2022-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 13,200 -66.58 1,227 -73.53 n/a n/a n/a
2022-05-16 2022-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 39,500 237.61 4,636 194.54 n/a n/a n/a
2022-02-14 2021-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 11,700 -23.03 1,574 -35.04 n/a n/a n/a
2021-11-15 2021-09-30 13F ASCENDIS PHARMA A Depository Receipt Put 15,200 16.03 2,423 40.63 n/a n/a n/a
2021-08-16 2021-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 13,100 16.96 1,723 19.40 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ASCENDIS PHARMA A SPONSORED ADR Put 11,200 21.74 1,443 -5.93 n/a n/a n/a
2021-05-17 2021-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 11,200 1,443 n/a n/a n/a
2021-02-16 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 9,200 100.00 1,534 116.06 n/a n/a n/a
2020-11-16 2020-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 4,600 58.62 710 65.50 n/a n/a n/a
2020-08-14 2020-06-30 13F ASCENDIS PHARMA A S Depository Receipt Put 2,900 -62.82 429 -51.14 n/a n/a n/a
2020-05-15 2020-03-31 13F ASCENDIS PHARMA A S Depository Receipt Put 7,800 122.86 878 80.29 n/a n/a n/a
2020-02-14 2019-12-31 13F ASCENDIS PHARMA A S Depository Receipt Put 3,500 -70.09 487 -56.79 n/a n/a n/a
2019-11-14 2019-09-30 13F ASCENDIS PHARMA A S Depository Receipt Put 11,700 37.65 1,127 15.12 n/a n/a n/a
2019-08-14 2019-06-30 13F ASCENDIS PHARMA A S Depository Receipt Put 8,500 -92.36 979 -92.53 n/a n/a n/a
2019-05-15 2019-03-31 13F ASCENDIS PHARMA A S Depository Receipt Put 111,300 13,100 n/a n/a n/a
2019-02-14 2018-12-31 13F ASCENDIS PHARMA A S Depository Receipt Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-13 2018-09-30 13F ASCENDIS PHARMA A S Depository Receipt Put 6,700 475 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.